C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. Total Liabilities 2021–2025
C4 Therapeutics Inc. annual total liabilities history from 2021 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- C4 Therapeutics Inc. total liabilities as of December 31, 2025: 102.5M, a 23.30% decrease year-over-year.
- C4 Therapeutics Inc. total liabilities for 2025 were 102.5M, a 23.30% decrease from 2024.
- C4 Therapeutics Inc. total liabilities for 2024 were 133.6M, a 2.52% increase from 2023.
- C4 Therapeutics Inc. total liabilities for 2023 were 130.3M, a 7.96% decrease from 2022.
- C4 Therapeutics Inc. total liabilities for 2022 were 141.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| C4 Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $102 |
| 2024 | $134 |
| 2023 | $130 |
| 2022 | $142 |
| 2021 | $117 |
C4 Therapeutics Inc. Total Liabilities — FAQ
C4 Therapeutics Inc. (CCCC) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's total liabilities history?
The chart and table above show C4 Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.